How the federal government limits valid scientific research on Cannabis sativa
- Details
- Category: Research
The use of medical marijuana for millions of patients suffering from a wide range of health conditions and the subsequent therapeutic benefits has long been documented. Twenty-three states, the District of Columbia, Puerto Rico, and Guam, have determined that Cannabis sativa (a.k.a. marijuana) can benefit patients suffering from a wide range of conditions, including cancer, epilepsy, chronic pain, and post-traumatic stress disorder.
Nanotechnology and math deliver two-in-one punch for cancer therapy resistance
- Details
- Category: Research
Math, biology and nanotechnology are becoming strange, yet effective bed-fellows in the fight against cancer treatment resistance. Researchers at the University of Waterloo and Harvard Medical School have engineered a revolutionary new approach to cancer treatment that pits a lethal combination of drugs together into a single nanoparticle.
More reasons to eat your broccoli
- Details
- Category: Research
Love it or hate it, broccoli is touted as a superfood, offering an array of health benefits. And it’s about to get even more super. University of Illinois researchers have identified candidate genes controlling the accumulation of phenolic compounds in broccoli. Consumption of phenolic compounds, including certain flavonoids, is associated with a lower risk of coronary heart disease, type II diabetes, asthma, and several types of cancer.
ClinicalTrials.gov vs. Drugs@FDA: A comparison of results reporting for new drug trials
- Details
- Category: Research
Pharmaceutical companies and other sponsors of clinical drug trials are required to report results to ClinicalTrials.gov, a registry run by the U.S. National Library of Medicine (NLM) at the National Institutes of Health (NIH). It's the largest clinical trials database, currently holding registrations from about 200,000 trials.
Natural molecule could improve Parkinson's
- Details
- Category: Research
The natural molecule, n-acetylcysteine (NAC), with strong antioxidant effects, shows potential benefit as part of the management for patients with Parkinson's disease, according to a study published in the journal PLOS ONE. Combining clinical evaluations of a patient's mental and physical abilities with brain imaging studies that tracked the levels of dopamine,
New drug clears psoriasis in clinical trials
- Details
- Category: Research
About 80 percent of patients with moderate to severe psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab, according to three large, long-term clinical trials led by Northwestern Medicine investigator Kenneth Gordon, MD, professor of Dermatology.
Probing proteins' 3-D structures suggests existing drugs may work for many cancers
- Details
- Category: Research
Examining databases of proteins' 3-D shapes, scientists at Washington University School of Medicine in St. Louis have identified more than 850 DNA mutations that appear to be linked to cancer. The information may expand the number of cancer patients who can benefit from existing drugs.
More Pharma News ...
- Personalized medicine leads to better outcomes for patients with cancer
- Promising treatment prospects for invasive breast cancer
- New insights into muscular dystrophy point to potential treatment avenues
- New class of protein could treat cancer and other diseases
- Fasting-like diet reduces multiple sclerosis symptoms
- Vitamin A may help improve pancreatic cancer chemotherapy
- Zika conspiracy theories on social media putting vulnerable people at risk